First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors. [PDF]
Powderly JD +9 more
europepmc +1 more source
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation. [PDF]
Baldini C +21 more
europepmc +1 more source
Exlibris Aulo-Gellio Severino Godinho
Sprechendes Exlibris.- Rot, orange Sonne gefüllt mit Text.- Inschrift: Exlibris XVI.- Inschrift: Aulo-Congresso .- Inschrift: Gélio Internacional .- Inschrift: Severino de Exlibris.- Inschrift: Godinho Lisoba 1976.- Inschrift: SOL LUCET.- Inschrift: OMNIBUS.- Inschrift: oku 55 ...
openaire +2 more sources
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study. [PDF]
Sands J +22 more
europepmc +1 more source
Proceedings of the seventh annual Women in Melanoma Conference. [PDF]
Najjar YG +25 more
europepmc +1 more source
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer. [PDF]
Smoragiewicz M +17 more
europepmc +1 more source
Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies. [PDF]
Sweis RF +19 more
europepmc +1 more source
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial. [PDF]
Yap TA +19 more
europepmc +1 more source
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. [PDF]
Kendra KL +32 more
europepmc +1 more source
Alkali-Activated Slag as Sustainable Binder for Pervious Concrete and Structural Plaster: A Feasibility Study. [PDF]
Coffetti D, Rapelli S, Coppola L.
europepmc +1 more source

